Cambron Christopher, Guttmannova Katarina, Fleming Charles B
Social Development Research Group, School of Social Work, University of Washington, 9725 3 Ave NE, Suite 401, Seattle, WA 98115.
Center for Studies in Demography & Ecology, University of Washington.
J Drug Issues. 2017 Jan;47(1):74-90. doi: 10.1177/0022042616678607. Epub 2016 Dec 21.
As of January 2016, 23 U.S. states and the District of Columbia have legalized medical or nonmedical cannabis, with more likely to follow. This dynamic policy context represents a substantial challenge for policy evaluation. Part I of this article provides a summary of state-level cannabis policy components across states and federal action regarding state-level policies. Part II presents a detailed history of cannabis policies in Washington State from 1998 to 2015 and analyzes the potential impacts of the policy changes on cannabis supply and demand. As an early adopter of both medical and nonmedical cannabis policies, Washington State provides an excellent example of the key elements to be considered in evaluating the relationship between policy changes and cannabis use. We highlight the importance of the interplay of federal enforcement priorities and previously adopted state-level cannabis regimes in interpreting the potential impacts of new cannabis policies.
截至2016年1月,美国23个州以及哥伦比亚特区已将医用或非医用大麻合法化,可能会有更多州效仿。这种动态的政策环境给政策评估带来了巨大挑战。本文第一部分概述了各州的州级大麻政策组成部分以及联邦政府针对州级政策采取的行动。第二部分详细介绍了华盛顿州1998年至2015年的大麻政策历史,并分析了政策变化对大麻供需的潜在影响。作为医用和非医用大麻政策的早期采用者,华盛顿州为评估政策变化与大麻使用之间的关系时应考虑的关键要素提供了一个绝佳范例。我们强调了在解释新大麻政策的潜在影响时,联邦执法重点与先前采用的州级大麻制度之间相互作用的重要性。